Validity and Reliability of the Turkish Version of the 'Breathing Vigilance Questionnaire'
Breathe-VQ
1 other identifier
observational
60
1 country
1
Brief Summary
In the literature, assessment questionnaires related to dyspnea measure beliefs about breathing-related symptoms but do not directly measure breath awareness. For this purpose, the Breath Vigilance Questionnaire (BVQ) is a subjective questionnaire developed from the Pain Awareness Questionnaire that directly measures breath-specific awareness and includes questions evaluating the interaction between conscious monitoring and control of breathing and anxiety. The questionnaire, consisting of 6 questions, was developed on healthy individuals and its validity and reliability were established. It uses a 5-point Likert scale from 1 (never) to 5 (always), with scores ranging from 6 to 30, and higher scores indicate higher breath awareness . The reliability and validity of the Turkish version of the Breath Vigilance Questionnaire will assist researchers in assessing dysfunctional breathing and developing treatment strategies by evaluating breath awareness. Therefore, the study aimed to investigate the validity and reliability of the Turkish version.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2026
CompletedStudy Start
First participant enrolled
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 10, 2026
April 22, 2026
April 1, 2026
1 month
April 6, 2026
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nijmegan Questionnaire
the Nijmegan Questionnaire, whose Turkish validity and reliability were established by Aslıhan et al., is the most frequently used test for the subjective assessment of dysfunctional respiration. The questionnaire, which allows for the evaluation and description of unexplained respiratory symptoms and signs of hyperventilation, consists of 16 items related to different systems such as cardiovascular, neurological, respiratory, gastrointestinal, and psychological factors, answered on a 5-point scale from 0 (never) to 4 (very often). A score greater than 23 indicates respiratory dysfunction. It has a sensitivity and specificity of 91% and 95%, respectively, regarding the clinical diagnosis of hyperventilation.
first day
Secondary Outcomes (1)
STAI
first day
Study Arms (1)
single group
descriptive study
Interventions
Eligibility Criteria
Healthy Participants
You may qualify if:
- individuals without a self-reported diagnosis of respiratory and/or cardiac problems
- individuals without a COVID-19 diagnosis and/or chronic COVID syndrome ("long COVID") within the last 3 months (primary respiratory dysfunction is excluded as we are dealing with this)
- individuals who can read and write in Turkish
You may not qualify if:
- Individuals with symptomatic heart disease, a history of lung surgery, neurological disorders, and malignancies that may affect exercise performance, and those with severe cognitive impairment who have difficulty understanding and completing the questionnaire items will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kütahya Health Sciences University
Kütahya, Kütahya, 43020, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SEVAL TAMER
Kütahya Health Sciences University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof . Dr
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 22, 2026
Study Start
April 10, 2026
Primary Completion (Estimated)
May 10, 2026
Study Completion (Estimated)
June 10, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04